Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Anesthesia Impact on Long-term Outcome in Elderly Cancer Surgery
NCT03012945Completed
- Sponsor
- Peking University First Hospital
- Start
- Nov 2014
- Primary completion
- Sep 2019
- Modality
- Targeted Liposomes, Orthosteric Ligands, Stealth (PEGylated) Liposomes
- Countries
- 1
01
Overview
Randomised, open-label trial of ropivacaine hydrochloride liposomal suspension injection and sufentanil in malignant solid tumor (2 arms), sponsored by Peking University First Hospital. Primary endpoint: Overall Survival at 5 years. Started Nov 2014; status: completed.
02
Drugs
ropivacaine hydrochloride liposomal suspension injectionsufentanil
03
Conditions
malignant solid tumor
Beyond the preview
Go deeper on NCT03012945.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03012945.